单倍体相合干细胞移植后的细胞因子释放综合征 - Suppr

Cytokine Release Syndrome after Haploidentical Stem Cell Transplantation.

作者信息

Teachey David T, Grupp Stephan A

机构信息

Division of Oncology, The Children's Hospital of Philadelphia and Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

出版信息

Biol Blood Marrow Transplant. 2016 Oct;22(10):1736-1737. doi: 10.1016/j.bbmt.2016.08.010. Epub 2016 Aug 16.

DOI:10.1016/j.bbmt.2016.08.010

PMID:27543158

Abstract

摘要

相似文献

Cytokine Release Syndrome after Haploidentical Stem Cell Transplantation.

Biol Blood Marrow Transplant. 2016 Oct;22(10):1736-1737. doi: 10.1016/j.bbmt.2016.08.010. Epub 2016 Aug 16.

[Establishment of a rhesus haploidentical hematopoietic stem cell and mesenchymal stem cell transplantation model by nonmyeloablative conditioning].

Zhonghua Xue Ye Xue Za Zhi. 2005 Jul;26(7):385-8.

[Haploidentical hematopoietic stem cell transplantation: Guidelines from the Francophone society of marrow transplantation and cellular therapy (SFGM-TC)].

Bull Cancer. 2016 Nov;103(11S):S229-S242. doi: 10.1016/j.bulcan.2016.09.007. Epub 2016 Nov 11.

Feasible outcomes of T cell-replete haploidentical stem cell transplantation with reduced-intensity conditioning in patients with myelodysplastic syndrome.

Biol Blood Marrow Transplant. 2015 Feb;21(2):342-9. doi: 10.1016/j.bbmt.2014.10.031. Epub 2014 Nov 20.

HLA-haploidentical T cell-depleted allogeneic hematopoietic stem cell transplantation in children with Fanconi anemia.

Biol Blood Marrow Transplant. 2014 Apr;20(4):571-6. doi: 10.1016/j.bbmt.2014.01.015. Epub 2014 Jan 22.

[Conditioning regimen containing fludarabine instead of cyclophosphamide for haploidentical hematopoietic stem cell transplantation].

Zhonghua Xue Ye Xue Za Zhi. 2009 Aug;30(8):514-8.

[Application of low dose of fludarabine and cyclophosphamide combined with donor NK Cells as a non-myeloablative conditioning regimen for the haploidentical hematopoietic stem cell transplantation in mice].

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007 Oct;15(5):1013-8.

Myeloablative haploidentical hematopoietic stem cell transplantation using basiliximab for graft-versus-host disease prophylaxis.

Hematology. 2015 Jul;20(6):313-9. doi: 10.1179/1607845414Y.0000000207. Epub 2014 Oct 16.

The relationship between circulating natural killer cells after reduced intensity conditioning hematopoietic stem cell transplantation and relapse-free survival and graft-versus-host disease.

Haematologica. 2008 Dec;93(12):1852-8. doi: 10.3324/haematol.13033. Epub 2008 Oct 22.

Rapid identification of cytokine release syndrome after haploidentical PBSC transplantation and successful therapy with tocilizumab.

Bone Marrow Transplant. 2016 Dec;51(12):1620-1621. doi: 10.1038/bmt.2016.229. Epub 2016 Sep 26.

引用本文的文献

Janus kinase inhibition in the treatment and prevention of graft-versus-host disease.

Front Immunol. 2024 Feb 6;15:1304065. doi: 10.3389/fimmu.2024.1304065. eCollection 2024.

Tocilizumab for Cytokine Release Syndrome Management After Haploidentical Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis.

Transplant Cell Ther. 2023 Aug;29(8):515.e1-515.e7. doi: 10.1016/j.jtct.2023.05.008. Epub 2023 May 12.

Cytokine Release Syndrome and Associated Acute Toxicities in Pediatric Patients Undergoing Immune Effector Cell Therapy or Hematopoietic Cell Transplantation.

Front Oncol. 2022 Mar 24;12:841117. doi: 10.3389/fonc.2022.841117. eCollection 2022.

Antithymocyte globulin plus post-transplant cyclophosphamide combination as graft-versus-host disease prophylaxis in haploidentical peripheral blood stem cell transplantation for hematological malignancies.

Int J Hematol. 2022 Apr;115(4):525-533. doi: 10.1007/s12185-021-03280-x. Epub 2022 Feb 28.

State of the CAR-T: Risk of Infections with Chimeric Antigen Receptor T-Cell Therapy and Determinants of SARS-CoV-2 Vaccine Responses.

Transplant Cell Ther. 2021 Dec;27(12):973-987. doi: 10.1016/j.jtct.2021.09.016. Epub 2021 Sep 27.

No differences in hemostatic and endothelial activations between haploidentical and matched-donor hematopoietic stem cell transplantation in thalassemia disease.

Thromb J. 2020 Sep 4;18(1):21. doi: 10.1186/s12959-020-00232-z.

Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE).

Haematologica. 2020 Jan 31;105(2):297-316. doi: 10.3324/haematol.2019.229781. Print 2020.

Pretransplant active disease status and HLA class II mismatching are associated with increased incidence and severity of cytokine release syndrome after haploidentical transplantation with posttransplant cyclophosphamide.

Cancer Med. 2020 Jan;9(1):52-61. doi: 10.1002/cam4.2607. Epub 2019 Nov 8.

Haploidentical Stem Cell Transplantation in Children with Benign Disorders: Improved Survival and Cost-Effective Care Over 15 Years from a Single Center in India.

Indian J Hematol Blood Transfus. 2019 Jul;35(3):426-430. doi: 10.1007/s12288-019-01087-9. Epub 2019 Jan 28.

Cellular therapy: Immune-related complications.

Immunol Rev. 2019 Jul;290(1):114-126. doi: 10.1111/imr.12768.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Cytokine Release Syndrome after Haploidentical Stem Cell Transplantation.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献